Ocular Therapeutix Inc (OCUL) support and resistance · rev $24.3M
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
This page maps Ocular Therapeutix Inc (OCUL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
OCUL currently screens at market cap $1.76B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new OCUL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the OCUL quote page for the session range and the stock page for the full model.
Not investment advice.